New software enhanced optical biometry and axial length measurement in eyes slated for cataract surgery, a study found.
Category: News
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling
InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company’s Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce…
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling
InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company’s Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce…
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling
InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company’s Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce…
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling
InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, today announced that patient enrollment was recently completed in the company’s Phase 1/2 clinical trial of ISV-303, a novel compound being developed to reduce…
Online Health Info Popular but Often Unchecked
The number of people looking for health information online is set to soar as workers return from holiday breaks, but few will check where the information comes from, according to an international survey released Tuesday. Reuters Health Information
Guidance on the referral of glaucoma suspects by community optometrists
This guidance relates to asymptomatic patients, those with symptoms should be treated according to current protocols. The guidance relates only to suspected glaucoma.
Published 20 December 2010, updates previous guidance of 17 December 2009.
Joint supplementary College guidance on supervision in relation to glaucoma related care by optometrists
This document refers to optometrists who have been trained to work in the field of glaucoma but who do not have a specialist qualification. It does not relate to optometrists with no training in the field.
Glaucoma Research Foundation Announces New Evidence For The Cause Of Vision Loss In Glaucoma
January is National Glaucoma Awareness Month and the Glaucoma Research Foundation today announced that novel new findings about the underlying cause of glaucoma have been published in the Proceedings of the National Academy of Sciences (Early Edition a…
Alkeus and Columbia University enter license agreement for potential therapies for dry-AMD, Stargardt disease
Alkeus Pharmaceuticals and Columbia University announced today that they have entered into a license agreement for a set of potential therapies for the treatment of dry age-related macular degeneration (dry-AMD), Stargardt disease, and other degenerati…
Alkeus Pharmaceuticals Licenses Novel Ophthalmologic Therapies From Columbia University With Applications In Dry-AMD And Stargardt’s Disease
Alkeus Pharmaceuticals and Columbia University announced today that they have entered into a license agreement for a set of potential therapies for the treatment of dry age-related macular degeneration (dry-AMD), Stargardt disease, and other degenerati…
Advanced Cell Technology Receives FDA Clearance For Clinical Trials Using Embryonic Stem Cells To Treat Age-Related Macular Degeneration
Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a leader in the field of regenerative medicine, announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to treat Dry Age-Related M…
Anti-Bacterial Effects Of Impregnating Plastics With Carbon Dioxide
Everyone has heard that carbon dioxide is responsible for global warming. But the gas also has some positive characteristics. Researchers are now impregnating plastics with compressed CO2 in a process that could lead to new applications ranging from co…
Intravitreal Ranibizumab Injections Safely, Effectively Treat Non-AMD CNV
Intravitreal ranibizumab showed potential benefit and a high safety profile in the treatment of choroidal neovascularization resulting from causes other than age-related macular degeneration, a study found.
Intravitreal Ranibizumab Injections Safely, Effectively Treat Non-AMD CNV
Intravitreal ranibizumab showed potential benefit and a high safety profile in the treatment of choroidal neovascularization resulting from causes other than age-related macular degeneration, a study found.
Through The Eyelid Tonometry for Glaucoma Testing
Intraocular pressure is usually measured by applying a force on the cornea using a tonometer. Although sufficiently accurate, tonometers are only used in ophthalmologist offices and so don’t measure intra-day pressures. They also fail with people pos…
FDA Approves Stem Cell Trial for Macular Degeneration
Advanced Cell Technology said on Monday it had won U.S. Food and Drug Administration approval to test human embryonic stem cells for treating macular degeneration, a common cause of vision loss. Reuters Health Information
Quarterly Ranibizumab Inferior to Monthly Injections for Macular Degeneration
It would have been nice if patients who take monthly intravitreal injections of ranibizumab (Lucentis) could have dropped back to quarterly injections instead, but a new study shows a less frequent schedule is also less effective at reducing vision los…
PanOptica completes $30 million Series A financing
PanOptica, Inc., a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies, today announced that it has raised $30 million in a Series A financing. This round was led by SV Life Sciences and Third Rock V…
New Research Reveals Unexpected Biological Pathway In Glaucoma
In a study published in the Proceedings of the National Academy of Sciences (Early Edition ahead of print), a team of researchers from the Kennedy Krieger Institute and four collaborating institutions, identified a new and unexpected biological pathway…